1. A Multi-institutional Study on the Mid-Term Outcomes of Single Anastomosis Duodeno-Ileal Bypass as a Surgical Revision Option After Sleeve Gastrectomy.
- Author
-
Zaveri H, Surve A, Cottam D, Ng PC, Enochs P, Billy H, Medlin W, Richards C, Belnap L, Sharp LS, Bermudez DM, Fairley R, Burns TA, Herrell K, Bull J, Menozzi SE, and Student JA
- Subjects
- Adult, Female, Humans, Hyperparathyroidism epidemiology, Hypertension surgery, Length of Stay statistics & numerical data, Lipids blood, Male, Middle Aged, Obesity, Morbid surgery, Patient Readmission statistics & numerical data, Postoperative Complications, Reoperation, Retrospective Studies, United States epidemiology, Vitamin K 1 blood, Weight Loss, Zinc blood, Anastomosis, Surgical, Duodenum surgery, Gastrectomy, Ileum surgery
- Abstract
Introduction: Recently, a single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) has become increasingly popular for patients with BMI > 50 as a primary or staged surgery. Staging allows surgeons to do the sleeve gastrectomy (SG) first with the conversion only happening when a failure or technical challenge is identified., Purpose: We present the mid-term outcomes of SADI bypass surgery after SG., Method: A retrospective analysis was performed on a prospective database from four institutions. Ninety-six patients were identified from 2013 to 2018. Patients were divided into two groups: one had two-stage SADI because of insufficient weight loss, the second had planned two-stage SADI because of super obesity (BMI > 50 kg/m
2 ). Incidence of complications was divided into < 30 days and > 30 days., Result: Of 96 patients, 3 patients were completely lost to follow-up. The mean age was 44.8 ± 11.3 years. There were no deaths or conversion to open surgery. The postoperative early complication and late complication rate was 5.3% and 6.4% respectively. At 24 months, group 2 had higher %weight loss (WL) and change in BMI units compared to group 1 with statistically significant difference. The average WL and change in BMI for entire patient's population at 24 months after 2nd stage SADI was 20.5% and 9.4 units respectively. The remission rate for DM was 93.7% with or without the use of medication., Conclusion: The two-stage approach to SADI-S appears technically simpler than a single compromised operation. However, this approach needs more patients to understand its limitations.- Published
- 2019
- Full Text
- View/download PDF